Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | PTPRB | P23467 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | SI | P14410 | 2/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1059738 | 0.86 | MME (0.56) | SMN1; SMN2MMECA14ALDH1A1CA12 | |
| SCHEMBL28741357 | 0.86 | MME (0.47) | SMN1; SMN2MMECA1CA2CA14 | |
| SCHEMBL13751258 | 0.86 | SMN1; SMN2 (0.40) | SMN1; SMN2MMECA1CA2CA14 | |
| SCHEMBL3687345 | 0.84 | SMN1; SMN2 (0.39) | SMN1; SMN2MMECA1CA2CA14 | |
| SCHEMBL11652987 | 0.82 | TDP1 (0.41) | CA1CA2TSHRALDH1A1ZDHHC7 | |
| SCHEMBL11652293 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2MMECA1CA2CA14 | |
| SCHEMBL7164419 | 0.79 | SMN1; SMN2 (0.43) | SMN1; SMN2MMECA1CA2CA14 | |
| SCHEMBL6696365 | 0.79 | SMN1; SMN2 (0.43) | SMN1; SMN2MMECA1CA2CA14 | |
| SCHEMBL2097237 | 0.79 | SMN1; SMN2 (0.50) | SMN1; SMN2MMECA1CA2CA14 | |
| SCHEMBL29120966 | 0.78 | SMN1; SMN2 (0.44) | SMN1; SMN2MMECA1CA2CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410276-B2 | Method of recycling polyurethane materials | CARPENTER ENGINEERED FOAMS BELGIUM BV (BE) | 2025-09-09 | — | — | US | disclosed |
| EP-4010414-B1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | CARPENTER ENG FOAMS BELGIUM BV (BE) | 2025-06-18 | — | — | EP | disclosed |
| US-20220325031-A1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | RECTICEL (BE) | 2022-10-13 | — | — | US | disclosed |
| EP-4010414-A1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | Recticel (BE) | 2022-06-15 | — | — | EP | disclosed |
| CN-114258410-A | Improved method for recycling polyurethane materials | 雷克蒂塞尔公司 | 2022-03-29 | — | — | CN | disclosed |
| US-9676686-B2 | Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device | JNC CORPORATION (JP) | 2017-06-13 | — | — | US | disclosed |
| US-9631142-B2 | Piperidine derivative, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-04-25 | — | — | US | disclosed |
| US-20160208172-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING NITROGEN-CONTAINING CYCLIC COMPOUND AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20160090534-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-03-31 | — | — | US | disclosed |
| US-4076601-A | FROM DIMETHYL MALONATE | MONSANTO COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090534-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | MBD2, SSB, MBTD1 | SMN1; SMN2 3753/4885MME 4026/4885CA1 725/4885 |
| US-20160208172-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING NITROGEN-CONTAINING CYCLIC COMPOUND AND LIQUID CRYSTAL DISPLAY DEVICE | CCND2, ROCK2, CCND1 | SMN1; SMN2 3119/4885MME 2663/4885CA1 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.